For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores.What are the Zacks Style Scores?Developed alon ...

McKessonCorporation (MCK) is well-poised for growth, backed by strategic collaborations and strength in the Distribution Solutions segment. However, the company’s opioid-related litigation expenses are a potential threat.Shares of this currently Zacks Rank #3 (Hold) company have risen 15.4% so far this year compared with the industry’s 6% growth. The S&P 500 Index has jumped 9.6% in the same time frame.McKesson is a healthcare services and information technology company with a market capitalization of $69.7 ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores.What a ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a v ...

Core Insights - McKesson reported a 15% revenue growth and 12.2% adjusted EPS growth in Q3 FY24, driven by strong performance in GLP-1 medications [2][3][4] - The company has a robust share buyback program, returning $2.6 billion to shareholders year-to-date, with $7.3 billion remaining in stock repurchase authorization [2][4] - McKesson's GLP-1 revenues reached $7.5 billion, contributing 60% to year-over-year growth, and represent approximately 9.3% of total group revenue [3][4][9] Financial Performance - In Q3 FY24, McKesson generated $100 million in free cash flow, totaling $2.9 billion over the trailing twelve months [2] - The company has raised its full-year outlook, projecting 11%-14% revenue growth and 8%-11% adjusted operating profit growth [6][7] - For FY25, McKesson anticipates a 9% revenue growth, with GLP-1 volumes expected to contribute an additional 3% to topline growth [9][10] Growth Drivers - The growth in GLP-1 medications is supported by a strong prior-authorization network, simplifying the reimbursement process for patients and pharmaceutical companies [4][5] - Market leaders like Novo Nordisk are expanding production, indicating a commitment to scaling up GLP-1 manufacturing, which benefits McKesson's distribution capabilities [4][5] - The opening of two new distribution centers in the U.S. is expected to further contribute to McKesson's growth [7] Valuation and Outlook - The fair value of McKesson's stock is maintained at $660 per share, with the stock trading at an attractive valuation of 14x free cash flow [11][14] - Projected operating profits and net profits are expected to grow modestly, with a focus on margin expansion despite lower margins from GLP-1 medications [11][12] - The company is expected to continue delivering strong growth momentum, with no significant surprises anticipated in Q4 FY24 results [7][8]

McKesson Corporation (MCK) reported third-quarter fiscal 2024 adjusted earnings per share (EPS) of $7.74, which beat the Zacks Consensus Estimate of $7.05 by 9.8%. The bottom line also improved 12% on a year-over-year basis.GAAP EPS was $4.42, down 42% from the year-ago quarter’s level. The significant decline was due to the provision of bad debts worth $515 million for uncollected trade accounts receivable related to the bankruptcy of Rite Aid Corporation. Moreover, the company recorded a pre-tax benefit o ...

McKesson Corporation Third Quarter Fiscal 2024 Earnings Call Cautionary Statements Cautionary Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward- looking statements may be identified by their use of terminology such as “believes,” “expects,” “anticipates,” “may,” “will,”“should,” “seeks,” “approximately,” “intends,” “projects,” “plans,” “estimates,” “targets,” or the ...

McKesson Corporation. (NYSE:MCK) Q3 2024 Earnings Conference Call February 7, 2024 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Eric Percher - Nephron Research Lisa Gill - JPMorgan Allen Lutz - Bank of America Brian Tanquilut - Jefferies Kevin Caliendo - UBS Eric Coldwell - Baird Stephanie Davis - Barclays Erin Wright - Morgan Stanley Daniel Gros ...

McKesson (MCK) reported $80.9 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 14.8%. EPS of $7.74 for the same period compares to $6.90 a year ago.The reported revenue represents a surprise of +4.41% over the Zacks Consensus Estimate of $77.48 billion. With the consensus EPS estimate being $7.05, the EPS surprise was +9.79%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 7th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived o ...